An on-chip cell culturing and combinatorial drug screening system
- 685 Downloads
A low-cost, convenient and precise drug combination screening microfluidic platform is developed, in which cell culture chambers designed with micropillars integrate with three laminar flow diffusion channels. This platform has several distinct features, including minimum shear stress on cells, biocompatibility, optimum concentration distribution and automatic combinatorial gradient generation, which can potentially speed up the discovery of an effective drug combination for cancer ablations. The presented device can generate two-drug combination gradients at the optimum flow rate of 90 μL/h and can be applied to identify the optimal combination of two clinically relevant chemotherapy drugs. For demonstration, paclitaxel at 0.77 × 10−3 mg/mL and cisplatin at 0.23 × 10−4 mg/mL were studied against lung cancer cells (A549). This microfluidic device has the potential to provide a precise and robust screening for anticancer combinational drugs practiced in clinics.
KeywordsDrug combination Cisplatin Paclitaxel Microfluidics A549 cells Cancer
This work was supported by National Natural Science Foundation of China (81301293) and National Science and Technology Major Projects for “Major New Drugs Innovation and Development” (2014ZX09507008).
- Ding X, Sanchez DJ, Shahangian A, Al-Shyoukh I, Cheng G, Ho C-M (2012) Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity. Int J 7:2281–2292Google Scholar
- Lam KS (1997) Mini-review. Application of combinatorial library methods in cancer research and drug discovery. Anti-cancer Drug Des 12:145–167Google Scholar
- Liebmann JE, Fisher J, Teague D, Cook JA (1993) Sequence dependence of paclitaxel (Taxol) combined with cisplatin or alkylators in human cancer cells. Oncol Res 6:25–31Google Scholar
- Silva A, Lee B-Y, Clemens DL, Kee T, Ding X, Ho C-M, Horwitz MA (2016) Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model. In: Proceedings of the national academy of sciences, 201600812Google Scholar
- Theodossiou C, Cook J, Fisher J, Teague D, Liebmann J, Russo A, Mitchell J (1998) Interaction of gemcitabine with paclitaxel and cisplatin in human tumor cell lines. Int J Oncol 12:825–832Google Scholar